Related Experiment Video
Updated: Jul 29, 2025

In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues
Published on: March 21, 2017
Octreotide and Octreotide-derived delivery systems
Mingliang Fan1, Yue Huang1, Xinlin Zhu2
1School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
Abstract:
Pharmaceutical peptide Octreotide is a somatostatin analog with targeting and therapeutic abilities. Over the last decades, Octreotide has been developed and approved to treat acromegaly and neuroendocrine tumours, and Octreotide-based radioactive conjugates have been leveraged clinically to detect small neuroendocrine tumour sites. Meanwhile, variety of Octreotide-derived delivery strategies have been proposed and explored for tumour targeted therapeutics or diagnostics in preclinical or clinical settings. In this review, we especially focus on the preclinical development and applications of Octreotide-derived drug delivery systems, diagnostic nanosystems, therapeutic nanosystems and multifunctional nanosystems, we also briefly discuss challenges and prospects of these Octreotide-derived delivery systems.
Insights
Octreotide, a somatostatin analog, shows promise in targeted cancer therapies and diagnostics. This review highlights Octreotide-derived delivery systems for preclinical tumor targeting, therapeutics, and diagnostics.
Area of Science:
- Pharmaceutical Science
- Oncology
- Nanotechnology
Background:
- Octreotide is a somatostatin analog approved for treating acromegaly and neuroendocrine tumors.
- Octreotide-based radioactive conjugates are used clinically for detecting neuroendocrine tumor sites.
- Various Octreotide-derived delivery strategies have been explored for targeted therapeutics and diagnostics.
Purpose of the Study:
- To review the preclinical development and applications of Octreotide-derived drug delivery systems.
- To focus on diagnostic, therapeutic, and multifunctional nanosystems derived from Octreotide.
- To discuss the challenges and future prospects of these Octreotide-derived delivery systems.
Main Methods:
- Literature review focusing on preclinical studies.
- Analysis of Octreotide-derived drug delivery systems, diagnostic nanosystems, therapeutic nanosystems, and multifunctional nanosystems.
- Discussion of challenges and prospects in the field.
Main Results:
- Octreotide-derived systems show potential for targeted drug delivery in preclinical settings.
- Diagnostic and therapeutic nanosystems based on Octreotide are being developed.
- Multifunctional nanosystems offer combined diagnostic and therapeutic capabilities.
Conclusions:
- Octreotide-derived delivery systems represent a promising area for preclinical cancer research.
- Further development is needed to address challenges and realize the full potential of these systems.
- These systems offer a versatile platform for advancing Octreotide-based cancer diagnostics and therapeutics.
More Related Videos
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Enteral Route
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...

